Skip to main content

Cti Biopharma Corp

CTICDelisted Jun 26, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0000891293

Cti Biopharma Corp was delisted on Jun 26, 2023; its insiders filed their last Form 4 on Jun 28, 2023; 133 institutions reported holding it in 13F filings for Q1 2023, worth $475.2M in total; no superinvestor held it.

13F holders, Q3 2023

Institutional positions in Cti Biopharma Corp as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

CTIC is no longer listed, and 13F filings after Q1 2023 list far fewer holders. See Q1 2023

Institutional holders
0
−2 vs. Q2 2023
Shares held
0
−102.0K (−100.0%) vs. Q2 2023
Total value
$0
−$474.2K (−100.0%) vs. Q2 2023
New holders
0
0 more added
Sold out
2
0 more reduced

Compare with Q2 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CTIC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2023: 0 institutions
Q1 2021: 55 institutionsQ2 2021: 50 institutionsQ3 2021: 56 institutionsQ4 2021: 63 institutionsQ1 2022: 92 institutionsQ2 2022: 119 institutionsQ3 2022: 133 institutionsQ4 2022: 145 institutionsQ1 2023: 133 institutionsQ2 2023: 2 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2023: $0
Q1 2021: $126.1MQ2 2021: $133.1MQ3 2021: $159.6MQ4 2021: $118.3MQ1 2022: $344.9MQ2 2022: $510.1MQ3 2022: $554.7MQ4 2022: $619.8MQ1 2023: $475.2MQ2 2023: $474.2KQ3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding CTIC and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20232$474.2K
Q1 2023133$475.2M
Q4 2022145$619.8M
Q3 2022133$554.7M
Q2 2022119$510.1M
Q1 202292$344.9M
Q4 202163$118.3M
Q3 202156$159.6M
Q2 202150$133.1M
Q1 202155$126.1M

Institutions, Q3 2023

Shares, value and share of portfolio for each institution holding Cti Biopharma Corp; share changes are against Q2 2023.

Institutions holding CTIC in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
UBS Asset Management Americas Inc0$00.00%−92,700−100.0%Sold out
Legal & General Group Plc0$00.00%−9,340−100.0%Sold out